Effectiveness of the Nplate Additional Risk Minimisation Materials Implemented in Australia (20210176)

Study summary

No information provided.

Study identification

• EU PAS number:
  EUPAS46340
• Study ID:
  49211
• Official title and acronym:
  Effectiveness of the Nplate Additional Risk Minimisation Materials Implemented in Australia (20210176)
• DARWIN EU® study:
  No
• Study countries:
  Australia
• Study description:
  No information provided.
• Study status:
  Finalised

Research institutions and networks

Institutions

Amgen

United States

Study timelines

Date when funding contract was signed

Planned:01/04/2022

Actual:01/04/2022

Study start date

Planned:01/04/2022

Actual:06/04/2022

Data analysis start date

Planned:01/06/2022

Actual:01/06/2022

Date of final study report

Planned:30/11/2022

Actual:25/01/2023

Sources of funding

Pharmaceutical company and other private sector 

More details on funding

Amgen

Regulatory

• Was the study required by a regulatory body?:
  Yes
• Is the study required by a Risk Management Plan (RMP)?:
  Non-EU RMP only